Scientists track a Drug's journey through the body
NCT ID NCT07211165
Summary
This early-stage study aimed to understand how the body processes a single dose of an experimental drug called clifutinib. Six healthy Chinese men received a dose containing a tiny, safe amount of radioactive tracer. Researchers then tracked how the drug was absorbed, broken down, and eliminated from the body through blood, urine, and stool samples to learn about its basic safety and processing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated hospital of Jiangnan University
Wuxi, Jiangsu, 214000, China
Conditions
Explore the condition pages connected to this study.